| Entry |
|
|---|
| Name |
Seractide acetate (USAN);
Seractide acetate hydrate;
Acthar gel-syntehtic (TN) |
|---|
| Formula |
C207H308N56O58S. C2H4O2. H2O
|
|---|
| Exact mass |
4616.2911
|
|---|
| Mol weight |
4619.13
|
|---|
| Structure |
 |
|---|
| Class |
Hormonal agent
DG01629 Adrenocorticotropic hormone (ACTH)
|
|---|
| Efficacy |
Melanocortin 2 receptor agonist |
|---|
| Type |
Modified peptide |
|---|
| Comment |
syntheses Adrenocorticotrophic hormone (ACTH) [CPD: C02017]
|
|---|
| Target |
|
|---|
| Pathway |
| hsa04080 | Neuroactive ligand-receptor interaction |
| hsa04925 | Aldosterone synthesis and secretion |
| hsa04927 | Cortisol synthesis and secretion |
|
|---|
| Interaction |
|
|---|
| Brite |
Drug groups [BR:br08330]
Hormonal agent
DG01629 Adrenocorticotropic hormone (ACTH)
D05827 Seractide acetate
Target-based classification of drugs [BR:br08310]
G Protein-coupled receptors
Rhodopsin family
Melanocortin
MC2R
D05827 Seractide acetate (USAN)
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
